Projecting long term effects of tobacco control. The RIVM chronic disease model

P. H. M. van Baal, T. L. Feenstra, R. T. Hoogenveen, H. C. Boshuizen (Bilthoven, Netherlands)

Source: Annual Congress 2006 - Smoking cessation
Session: Smoking cessation
Session type: Poster Discussion
Number: 2310

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. H. M. van Baal, T. L. Feenstra, R. T. Hoogenveen, H. C. Boshuizen (Bilthoven, Netherlands). Projecting long term effects of tobacco control. The RIVM chronic disease model. Eur Respir J 2006; 28: Suppl. 50, 2310

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment of variations in control of asthma over time
Source: Eur Respir J 2003; 22: 298-304
Year: 2003



Role of tobacco exposure in the course of COVID-19 disease and the impact of the disease on smoking behavior
Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes
Year: 2021


Is it possible to predict asthma outcomes? A disease model for economic analysis.
Source: International Congress 2017 – Asthma management
Year: 2017

Integrated disease management (IDM) intervention for COPD patients has long-term effects on patient activation
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Present and future costs of COPD in Iceland and Norway: results from the BOLD study
Source: Eur Respir J 2009; 34: 850-857
Year: 2009



Projections of the future burden of COPD in the Netherlands by disease severity using a dynamic population model of disease progression
Source: Eur Respir J 2004; 24: Suppl. 48, 700s
Year: 2004

Late Breaking Abstract - The effect of comorbidity on the course and outcomes of COPD in observation in the primary health care, including on the background of the COVID-19 pandemic: a comparative analysis.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Prevention, socio-economic consequences and compensation issues
Source: Annual Congress 2005 - Occupational asthma
Year: 2005

Short and long term effects of PR. Can patients benefit of a short maintenance program?
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008


Are systemic manifestations ascribable to COPD in smokers? A structural equation modeling approach.
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014

Workplace smoking restriction and respiratory health: the Irish experience
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005

The effects of clinically relevant reference agents in a mouse model of severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015


Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention
Source: Eur Respir J 2006; 28: 397-408
Year: 2006



Health status and chronic conditions in patients with COPD and their resident loved ones
Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases
Year: 2015

Health, social and economic consequences of chronic obstructive pulmonary disease (COPD): A controlled national study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012


Does improvement in health status affect long term mortality in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 248s
Year: 2002

Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I
Source: Annual Congress 2003 - Burden of asthma
Year: 2003


The effect of regional differences on visual arts interpretation in exacerbation and stable periods of chronic airway diseases
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016